84 search results for “target therapy” in the Staff website
-
Erica Bohnen
Faculty of Social and Behavioural Sciences
-
Oncode Accelerator funds preclinical development of cancer therapies
Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.
-
Jessy Terpstra
Faculty of Social and Behavioural Sciences
-
Developing new therapies to fight muscle disease
Biophysicist Alireza Mashaghi and his collaborators are taking up the fight against muscular dystrophy: genetic disorders that cause muscle weakness. They want to inhibit the clumping of proteins that results in toxic aggregates. For this, the team receives 550,000 euros from Health Holland. The team…
-
LUMC signs international agreement on developing Advanced Therapy Medicinal Products
Skåne University Hospital, Lund University and Leiden University Medical Center will work together to expand their research, teaching and development relating to Advanced Therapy Medicinal Products. That is the essence of a Memorandum of Understanding signed at SciLifeLab near Stockholm on Wednesday…
-
Tom van der Wel -
X-ray mirrors: useful in space, but also for radiation therapy
A special type of mirror to reflect X-rays has more possible applications than space research. Targeted radiation therapy for cancer, for example. Next to his full-time job, physicist David Girou mapped out the possibilities. He will receive his PhD on 14 June.
-
patient in the Netherlands successfully treated with stem cell gene therapy
Researchers from the Leiden University Medical Center (LUMC) have successfully used stem cell gene therapy to treat a baby with the severe congenital immune disorder SCID. An important milestone: it is the first time stem cell gene therapy of Dutch origin has been administered to a patient, and also…
-
Marike KooistraFaculty of Social and Behavioural Sciences
-
Johanna Greeven
Faculty of Social and Behavioural Sciences
-
Erik Danen -
Danielle OprelFaculty of Social and Behavioural Sciences
-
Tessa Hagens -
Bianca BoyerFaculty of Social and Behavioural Sciences
-
Paul Hooykaas -
Adriaan IJzerman -
Cleveringa professors target of hate campaigns: ‘Intimidation frustrates Holocaust research’
Holocaust scholars Barbara Engelking and Jan Grabowski will jointly hold the Cleveringa lecture on November 26. They were accused of defamation in Poland for a book they co-edited. How has this affected them? ‘This is an attempt to wear us down.’
-
Judith Bovée -
Mara van OschFaculty of Social and Behavioural Sciences
-
Oana Georgiana Rus-OswaldFaculty of Social and Behavioural Sciences
-
Lioe-Fee de Geus-Oei -
Webinar Transfusion Medicine and Cellular and Tissue Therapies
Study information
-
Daisy Batenburg -
Andraniek Evadgian -
Kim Elbertse -
Elsa Neubert -
Eveline Bleiker -
John Haanen -
Sylvestre Bonnet -
Jeroen Jansen -
Annaloes Fokkelman-Klip -
Sabine de Winter -
Michiel van Dijk -
Michiel van de Sande -
Jannie Keyser-Borst -
Jelle Wesseling -
Vincent Smit -
Chenlin Feng -
Health insurance
If you wish, you can take part in the collective health insurance scheme offered by Leiden University and Zorg en Zekerheid. This scheme offers a collective discount, for you and your family.
-
Gregorius Luyten -
Koos van der Hoeven
-
Peter ten Dijke -
Hein Putter -
Maarten Vermeer -
Manfred Wuhrer -
Henri Versteeg -
Psychologist for PhD candidates
If you’re working on a PhD track and are experiencing psychological issues, you can contact one of the psychologists for PhD candidates for help with problems that have arisen during the PhD process or are directly affecting this.
-
Medical Delta professor Marco van Vulpen: ‘I advocate the introduction of the share factor’
Proton therapy is a new way of treating cancer in which radiation doses are delivered more precisely. This results in less damage to surrounding tissue and fewer side effects. Professor Marco van Vulpen is medical director of HollandPTC in Delft, where the social value of this therapy is studied. Van…
-
Vidi grants for 12 researchers from Leiden University
An impressive 12 researchers from Leiden University have been awarded an 800,000-euro grant by the Dutch Research Council (NWO). This will enable them to develop their own line of research over the next five years.
-
RARE-NL: LUMC joins consortium to find treatments for rare diseases
RARE-NL, a new collaboration between university hospitals, hopes to find treatments for rare diseases. Professor Teun van Gelder is representing the LUMC in the initiative.